John McFall, a British Paralympian and surgeon who lost his right leg in a motorcycle accident, is closer than ever to becoming the first astronaut with a physical disability to reach orbit. Britain has struck an agreement that could place McFall aboard Vast’s Haven-1 commercial space station as early as 2027, a timeline that aligns with Vast’s growing role in human spaceflight. The arrangement sits at the intersection of two separate but converging tracks: ESA’s years-long study into whether disabled astronauts can safely fly long-duration missions, and a commercial station builder’s rapid accumulation of NASA-backed credentials.
Why McFall’s 2027 flight window matters right now
The practical tension behind this deal is straightforward. Government space agencies have spent decades applying medical screening standards that effectively excluded anyone with a significant physical disability from crewed missions. Those standards have not been formally rewritten. Yet commercial operators like Vast are now assembling their own crew rosters for privately funded flights, and they face no obligation to mirror NASA’s or ESA’s legacy medical requirements when selecting non-government passengers.
That gap creates a real opening. ESA’s Fly! program, which placed McFall in the agency’s astronaut reserve in 2022, was designed to test whether the old exclusions hold up under modern engineering and medical evidence. The feasibility study concluded in January 2025 after evaluating approximately 80 considerations spanning training, spacecraft operations, space station operations, medical fitness, and crew support. Its finding, according to ESA’s own program documentation, “strongly supports” that astronauts with physical disabilities can fly long-duration missions.
If McFall reaches Haven-1 in 2027, it would happen well before either NASA or ESA has formally updated its own astronaut medical requirements to reflect that conclusion. Commercial station operators, in other words, may set the practical standard for inclusive crew selection years ahead of the agencies whose research made it possible. For advocates of disability inclusion, that would mark a symbolic break from the era when spaceflight was reserved for a narrowly defined notion of physical “perfection.”
Vast’s NASA track record and Haven-1 hardware progress
Vast is not an unknown startup pitching a concept. The company first publicly announced the Haven-1 and Vast-1 missions in May 2023 through a formal business release. Since then, it has built a documented relationship with NASA that extends across multiple programs. Vast holds an unfunded Space Act Agreement with NASA, under which the agency has provided technical testing support for Haven-1, including work on an air filtration and atmosphere safety system. That kind of hands-on hardware evaluation signals that Haven-1 development has moved past the slide-deck stage into physical testing with government oversight.
Separately, NASA selected Vast to conduct the sixth private astronaut mission to the International Space Station, a flight NASA describes in its own announcement of the mission as targeting launch no earlier than summer 2027. That ISS mission is distinct from Haven-1, but the selection confirms Vast’s standing as a vetted operator within NASA’s broader commercial spaceflight portfolio. It places Vast alongside other companies that NASA is encouraging to develop crew transportation and on-orbit services.
Vast also appears in NASA’s overview of commercial space station partners, where the agency outlines how private stations are expected to take over many functions of the aging International Space Station. NASA’s strategy envisions multiple commercial platforms in low-Earth orbit providing laboratory space, technology demonstration capability, and opportunities for private astronaut missions. Haven-1 is positioned as one of the earlier, smaller-scale entrants in that ecosystem, designed to host a handful of crew members on relatively short missions.
For McFall’s potential flight, these credentials matter because they demonstrate that Haven-1 is being developed under conditions that NASA engineers have directly evaluated. A commercial station that has passed NASA air-quality and safety benchmarks carries more credibility than one built entirely outside government review, even if the crew selection process itself remains a private decision. The more Haven-1 looks like a node within NASA’s emerging commercial LEO framework, the easier it becomes for a national government such as the UK to justify placing a high-profile astronaut candidate on board.
What ESA’s Fly! study proved and what it left open
ESA’s Fly! feasibility study is the strongest piece of institutional evidence supporting McFall’s candidacy. The study assessed roughly 80 factors across five domains and concluded with a clear endorsement of disabled astronaut participation in long-duration missions. No previous space agency had conducted an assessment of comparable scope, and the work goes beyond simple medical screening to look at operational realities such as emergency egress, spacesuit handling, and maintenance tasks in microgravity.
The study’s limitation is that ESA has published only high-level summaries of its findings. The full dataset, the specific medical protocols developed for prosthetic-limb accommodation in microgravity, and the detailed engineering modifications recommended for spacecraft interfaces have not been released publicly. That matters because other operators, whether commercial or governmental, cannot easily replicate or build on the work without access to the underlying analysis. For now, much of the expertise remains locked inside ESA and its contractors.
ESA has also not announced a concrete flight assignment for McFall on any of its own missions. His reserve status means he is trained and eligible but not scheduled. The British agreement to fly him on Haven-1 effectively routes around that bottleneck by placing him on a commercial vehicle rather than waiting for an ESA crew slot to open. Politically, that allows the UK to showcase a pioneering astronaut without depending on the limited cadence of ESA flights, while still leveraging ESA’s training infrastructure and medical research.
At the same time, the Fly! conclusions raise questions that only an actual mission can answer. How will a lower-limb amputee adapt to the ergonomics of a small commercial station where handholds, foot restraints, and workstations were designed with able-bodied crew in mind? What modifications, if any, will be made to exercise equipment, emergency masks, or docking hatches? And how will mission planners balance the need for realistic operational testing with the understandable desire to minimize additional risk on a first-of-its-kind flight?
Gaps in the public record and what to watch next
Several pieces of this story remain unconfirmed by primary documentation. No signed agreement text between the UK government and Vast has been published. Direct statements from McFall or UK Space Agency officials describing the specific terms of a 2027 flight commitment are absent from available primary sources. For now, the existence of a British-backed plan to send McFall to Haven-1 rests on secondary reporting and statements that stop short of a formal manifest.
There is also no public confirmation that Vast has locked in a specific launch provider, spacecraft configuration, or mission duration for a McFall flight to Haven-1. The company’s previously announced plans have referenced crewed missions but have not detailed how many seats would be allocated to government-sponsored astronauts versus private customers, or how medical integration for a disabled crew member would be handled. Until those mission design choices are disclosed, it will be difficult for outside experts to assess how closely the flight adheres to the scenarios modeled in ESA’s Fly! study.
For observers, several milestones will help clarify whether McFall is truly on a path to orbit in 2027. One is the publication of any binding agreement or memorandum of understanding between the UK and Vast that specifies launch windows, training timelines, and financial commitments. Another is evidence that Haven-1 hardware has progressed from subsystem testing to full-scale environmental qualification, a step that would make a 2027 launch more than aspirational. Finally, any move by ESA to update its own medical standards in line with Fly! would signal that agency practice is catching up to the inclusive future its research already supports.
Until those developments occur, McFall’s prospective mission occupies a liminal space: more concrete than a thought experiment, yet not fully anchored in publicly verifiable contracts and hardware readiness. The convergence of ESA’s disability-focused research, NASA’s support for commercial stations, and Vast’s emerging capabilities has created a plausible pathway for the first astronaut with a significant physical disability to reach orbit. Whether that pathway leads to a launch in 2027 will depend on decisions over the next two years that, for now, are being made largely out of public view.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
